Shaanxi Meibang Pharmaceutical Group Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shaanxi Meibang Pharmaceutical Group Co., Ltd.

Why is Shaanxi Meibang Pharmaceutical Group Co., Ltd. ?

High Debt Company with a Debt to Equity ratio (avg) at times

Poor long term growth as Net Sales has grown by an annual rate of 9.81% and Operating profit at -42.10% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times
The company has been able to generate a Return on Equity (avg) of 7.87% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of 9.81% and Operating profit at -42.10% over the last 5 years

Flat results in Sep 25

INTEREST(HY) At CNY 0.03 MM has Grown at 2,402.22%
PRE-TAX PROFIT(Q) At CNY -1.11 MM has Fallen at -220.55%

With ROE of 1.90%, it has a very expensive valuation with a 2.56 Price to Book Value

Over the past year, while the stock has generated a return of 7.63%, its profits have fallen by -33.2%

Underperformed the market in the last 1 year

The stock has generated a return of 7.63% in the last 1 year, much lower than market (China Shanghai Composite) returns of 22.49%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shaanxi Meibang Pharmaceutical Group Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Shaanxi Meibang Pharmaceutical Group Co., Ltd.

26.56%

1.33

58.37%

China Shanghai Composite

16.01%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

9.81%

EBIT Growth (5y)

-42.10%

EBIT to Interest (avg)

60.71

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.22

Sales to Capital Employed (avg)

0.63

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

53.19%

Pledged Shares

Institutional Holding

ROCE (avg)

8.59%

ROE (avg)

7.87%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

135

Industry P/E

Price to Book Value

2.56

EV to EBIT

1137.26

EV to EBITDA

140.76

EV to Capital Employed

2.98

EV to Sales

3.15

PEG Ratio

Dividend Yield

ROCE (Latest)

0.26%

ROE (Latest)

1.90%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company

INVENTORY TURNOVER RATIO(HY)

Highest at 3.51 times

DIVIDEND PAYOUT RATIO(Y)

Highest at 12,500%

RAW MATERIAL COST(Y)

Fallen by -14.66% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 4.76 times

DIVIDEND PER SHARE(HY)

Highest at CNY 4.76

NET PROFIT(Q)

At CNY -0.26 MM has Grown at 92.57%

-11What is not working for the Company

INTEREST(HY)

At CNY 0.03 MM has Grown at 2,402.22%

PRE-TAX PROFIT(Q)

At CNY -1.11 MM has Fallen at -220.55%

Here's what is working for Shaanxi Meibang Pharmaceutical Group Co., Ltd.

Inventory Turnover Ratio

Highest at 3.51 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Net Profit

At CNY -0.26 MM has Grown at 92.57%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Debtors Turnover Ratio

Highest at 4.76 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Dividend per share

Highest at CNY 4.76

in the last five years

MOJO Watch

Company is distributing higher dividend from profits generated

DPS (CNY)

Dividend Payout Ratio

Highest at 12,500%

in the last five years

MOJO Watch

Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost

Fallen by -14.66% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shaanxi Meibang Pharmaceutical Group Co., Ltd.

Interest

At CNY 0.03 MM has Grown at 2,402.22%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Pre-Tax Profit

At CNY -1.11 MM has Fallen at -220.55%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)